CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Communication Bridge™behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05697380
NCT05697380N/ACompleted

Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia 3.0 Pilot

University of Chicago·interventional·Posted Jan 25, 2023·Updated Oct 16, 2024

In Brief

A clinical study evaluating Communication Bridge™ for Aphasia and 4 related conditions. Completed, enrolled 8 participants across 1 site.

Detailed Summary

This study will evaluate evidence-based treatments for adults with mild Primary Progressive Aphasia (PPA). The aim of the study is to help identify efficacious communication and quality of life interventions for those with PPA and their care-partners. Participants with a diagnosis of PPA and their actively-engaged care partners will be involved in the study for 12 months. Each participant will receive a iPad equipped with the necessary applications and features for the study. Participants will complete evaluations, speech therapy sessions with a speech and language therapist, and sessions with a licensed social worker or related clinician. They will have access to Communication Bridge, a personalized web application to practice home exercises that reinforce treatment strategies. There are no costs to participate in this study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 25, 2023
Enrollment StartJun 1, 2021
Primary CompletionJul 12, 2023
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 3.4 years ago

Interventions

Communication Bridge™behavioral

Evidence-based speech language therapy treatment will be compared and contrasted.